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Recurrences and related characteristics of gastric cancer
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Summary We analysed data on 1117 patients with gastric cancer who were treated by curative resection.
Attention was focused on invasion and a recurrence of the cancer. Based on a univariate analysis, death
following a recurrence and prognosis were related to age of the patients, size of the tumour, tumour location,
tumour tissue differentiation, growth pattern, depth of invasion, lymphatic and vascular invasion and lymph
node metastasis. In proportion to the growth potential, determined by the level of proliferating cell nuclear
antigen (PCNA) labelling, the death related to a recurrence was increased and the prognosis was poorer.
Multivariate analysis showed that the three factors of serosal invasion, PCNA labelling index and lymph node
dissection were independent prognostic factors. When sites ofrecurrence were analysed regarding each depth of
invasion, haematogenous recurrence, in particular in the liver, occurred even in cases of an early invasion and
many types of recurrences, including peritoneal recurrence, were noted in patients with an advanced state of
invasion.
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With emphasis on early diagnosis and detection of gastric
cancer, prophylactic lymph node dissection and post-
operative chemotherapy, the prognosis of patients with
gastric cancer has improved (Maehara et al., 1994, 1995a).
However, recurrences are likely to take on a variety of forms
and in different organs, even after curative resection of a
gastric cancer (Baba et al., 1989; Ichiyoshi et al., 1990;
Moriguchi et al., 1992a). Recurrences were noted at each
level of depth of tumour invasion and the rate of recurrences
was increased in proportion to the degree of depth of
invasion (Moriguchi et al., 1992b). Risk factors for peritoneal
recurrence were reported to be serosal invasion and
Borrmann type IV and those for haematogenous recurrence
were lymph node metastasis and vessel involvement
(Moriguchi et al., 1992a). However, there are few reports
on patterns of recurrence with regard to each depth of
invasion. When designing a post-operative follow-up system
for gastric cancer after curative resection, it is important to
examine the type of recurrence at each depth of tumour
advance into the stomach wall. We determined clinicopatho-
logical and biological characteristics of gastric cancer with
recurrences, and the type of recurrence at each level of
tumour invasion was given attention.
Patients and methods
Patients and surgical treatment
From 1965 to 1987, 1117 Japanese patients with gastric cancer
and no evidence of any other malignancy underwent gastric
curative resection in the Department of Surgery II, Kyushu
University Hospital, Fukuoka, Japan. Standardised proce-
dures were: gastric resection was done, after determining the
resection line 3 cm apart from the macroscopic edge for the
localised tumour, and 6 cm for the infiltrative tumour
(Kawasaki, 1975; Bozzetti et al., 1982). Prophylactic lymph
node dissection of more than D2 resection was carried out
(Maehara et al., 1992). Complete excision of invaded organs
was done irrespective of the number of sites on the organs,
when there was no evidence of incurable factors such as
peritoneal dissemination, liver metastasis and widespread
nodal involvement (Korenaga et al., 1988a). All patients were
examined clinically and pathologically with respect to the
factors given in Table I. Pathological diagnosis and classifica-
tion ofthe resected gastric cancer tissues were made according
to the General Rules for Gastric Cancer Study in Surgery and
Pathology in Japan (Japanese Research Society for Gastric
Cancer, 1981, 1993). The lymph nodes in groups 1,2 and 3 are
referred to as nI, n2 and n3, respectively, based on lymph node
metastasis. Lymph node dissection was classified as follows:
Dl, complete removal of group 1 lymph node alone; D2,
complete removal of group 1 and 2 lymph nodes; and D3,
complete removal of group 1,2 and 3 lymph nodes.
Eight patients (0.7%) died within the first 30 post-
operative days and outcome for two (0.2%) was unknown.
Of the 1107 patients, 475 are alive, 351 died with a recurrence
of the gastric cancer, 248 died with another disease and 33
died of undetermined causes. Death owing to causes other
than gastric cancer were considered as censored data in the
statistical analysis.
Staining for proliferating cell nuclear antigen (PCNA)
Sections of 5 ym from paraffin blocks were dewaxed in
xylene, rehydrated through a graded series of ethanol and
immersed in 3% hydrogen peroxide in methanol. These
sections were subsequently washed in phosphate-buffered
saline, and normal goat serum was applied to reduce non-
specific binding. The primary antibody PC10, a monoclonal
mouse antibody for rat PCNA, was purchased from Dako
Corp (Carpinteria, CA, USA). The sections were incubated
for 2 h with PCIO (dilution 1:20) at room temperature, then
with biotinylated goat anti-mouse IgG (1:200 for 1 h), and
finally with the avidin-biotin-peroxidase complex (Kakeji et
al., 1994). Peroxidase labelling was developed with 3,3'-
diaminobenzidine and hydrogen peroxide, and the sections
were counterstained with haematoxylin. All stained nuclei
were scored as positive for PCNA. The PCNA labelling index
was determined by observing 1000 nuclei in areas of the
section with the highest labelling frequency, and the
percentage of PCNA-labelled nuclei (PCNA labelling index)
was used for analysis.
Statistical analysis
The BMDP statistical package program (BMDP; Los
Angeles, CA, USA) for the IBM (Armonk, NY, USA)
3090 mainframe computer was used for all analyses (Dixon,
1988). The BMDP P4F and P3S programs were used for the
chi-square test and the Kruskal-Wallis test to compare data
on the groups. The BMDP PIL program was used to analyse
survival time by the Kaplan-Meier method and the Mantel -
Cox test was used to test for equality of the survival curves.
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The BMDP P2L program was used for simultaneous
multivariate adjustment of all covariates by the Cox
regression analysis with forward stepwise model (Cox, 1972;
Maehara et al., 1991a). The level of significance was P<0.05.
Results
Clinicopathological factors
At the time of analysis, the median follow-up time was 12.0
years for recurrence-free patients. Table I shows clinico-
pathological data on the 756 recurrence-free patients and on
the 351 patients who died following a recurrence, all of whom
underwent gastric resection. The rate of a recurrence-related
death and 5 year survival was analysed regarding each
clinicopathological factor. There was no gender difference in
the rate of recurrence and prognosis. Death related to a
recurrence was increased and the prognosis was poorer with
increasing age of the patient and with tumour size. When the
entire stomach was involved, the tumour was undifferentiated
with infiltrative growth and the rates of lymphatic and
vascular involvement and lymph node metastasis were higher,
the rate of death related to recurrence was higher and the
prognosis was poorer. In proportion to the depth ofinvasion,
the recurrence-related death was increased and the prognosis
was also poorer.
Table I Clinicopathological factors and recurrence of gastric cancer
Recurrence Five-year
Total Recurrence-free and death survival
Factor (n=1107) (n= 756) (n=351) (%) P-valuea
Sex
Male
Female
Age (years)
<49
50 - 69
,70
Maximum tumour diameter (cm)
<4.9
5.0 - 9.9
>10.0
Tumour location
Upper
Middle
Lower
Whole stomach
Histology
Differentiated
Undifferentiated
Specificb
Unknownb
Depth of invasion
m
sm
pm
ss
se
si and sei
Histological growth pattern
Expansive
Intermediate
Infiltrative
Unknownb
Lymphatic involvement
ly(-)
ly(+)
Unknownb
Vascular involvement
v(-)
v(+)
Unknownb
Lymph node metastasis
n(-)
n(+)
Gastric resection
Partial
Total
Unknownb
Lymph node dissection
DO and Dl
D2 and D3
760 (100.0)
347 (100.0)
256
637
214
516
470
121
224
369
469
45
569
532
4
2
203
213
125
130
380
56
214
325
438
130
494
357
256
693
107
307
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
515 (67.8)
241 (69.5)
186
430
140
440
276
40
(100.0)
(100.0)
(100.0)
(100.0)
134
282
325
15
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(72.7)
(67.5)
(65.4)
(85.3)
(58.7)
(33.1)
245 (32.2)
106 (30.5)
70
207
74
76
194
81
90
87
144
30
155
195
1
0
(59.8)
(76.4)
(69.3)
(33.3)
414 (72.8)
337 (63.3)
3
2
192
192
90
86
180
16
174
223
237
122
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
613 (100.0)
494 (100.0)
759
329
19
(100.0)
(100.0)
108 (100.0)
999 (100.0)
(94.6)
(90.1)
(72.0)
(66.2)
(47.4)
(28.6)
(81.3)
(68.6)
(54.1)
408 (82.6)
183 (51.3)
165
506 (73.0)
54 (50.5)
196
522 (73.0)
234 (47.4)
567 (74.7)
177 (53.8)
12
74 (68.5)
682 (68.3)
11
21
35
44
200
40
40
102
201
8
86
174
91
(27.3)
(32.5)
(34.6)
73.5
73.8
77.9
73.9
66.8
(14.7)
(41.3)
(66.9)
(40.2)
(23.6)
(30.7)
(66.7)
89.8
63.9
40.8
64.7
82.5
74.8
29.4
(27.2)
(36.7)
(5.4)
(9.9)
(28.0)
(33.8)
(52.6)
(71.4)
78.1
68.8
96.8
95.6
81.1
77.7
51.5
27.1
(18.7)
(31.4)
(45.9)
87.1
75.8
59.5
(17.4)
(48.7)
187 (27.0)
53 (49.5)
111
91 (14.8)
260 (52.6)
192 (25.3)
152 (46.2)
7
34 (31.5)
317 (31.7)
85.4
56.1
76.7
53.6
91.0
52.2
81.0
55.9
76.1
73.4
0.6648
0.0079
<0.0001
0.0001
0.0004
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
0.9587
a, Log-rank analysis. b, Cases excluded from statistical analysis. m, mucosa; sm, submucosa; pm, muscularis propria; ss, subserosa; s.e, serosa
(exposed); si, serosa (infiltrating adjacent tissue), sei, coexistance ofexposed and infiltrating serosa. Percentages in brackets.Characterisitcs of gastric cancer
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Table II PCNA labelling index and recurrence of gastric cancer
Recurrence Five-year
Total Recurrence-free and death survival
Factor (n= 155) (n=91) (n=64) (%) P-value
PCNA labelling index (%)
<20.0 47 (100.0) 45 (95.7) 2 (4.3) 96.8 <0.0001
20.0- 39.9 55 (100.0) 37 (67.3) 18 (32.7) 69.2
,40 53 (100.0) 9 (17.0) 44 (83.0) 20.0
Percentages in brackets.
PCNA labelling
Growth potential of gastric cancer tissues was evaluated by
PCNA labelling and the level was grouped into three. The
recurrence-related death was increased and the prognosis was
poorer in cases of a higher PCNA labelling (P<0.0001)
(Table II).
Multivariate analysis
To determine which of the covariates listed in Table I and the
PCNA labelling index were important prognostic factors of
survival time for patients with gastric cancer, a multivariate
analysis with Cox regression analysis with forward stepwise
model was done for 155 cases. Serosal invasion, the PCNA
labelling index and extended lymph node dissection proved to
be independent factors (P<0.05) (Table III).
Recurrence pattern
Data on 351 patients who died with a recurrence were
analysed with respect to the pattern of recurrence (Table IV).
Recurrences were detected at multiple sites in 40 patients.
Haematogenous recurrences including liver recurrence were
noted at each level of invasion. In cases of advanced
invasion, a variety of areas of recurrence, including the
peritoneum and distant organs of lung, bone and brain was
evident. With regard to change in the rate of peritoneal
recurrence at each depth of invasion, there was a significant
difference among the six groups with regard to depth of
invasion (P=0.0251). Local recurrences were equal at each
0-9
L-
g3
Table III Cox regression analysis for patients with gastric cancer
Prognosticfactor Relative risk
(observed value) P-value (95% confidence interval)
Serosal invasion <0.0001 6.5427 (2.0513 - 20.810)
(none, present)
PCNA labelling index <0.0001 1.1298 (1.0874 - 1.1739)
(per one labelling index)
Lymph node dissection <0.01 0.0905 (0.0210 - 0.3886)
(DO and Dl, D2 and D3)
level of invasion into the gastric wall. There was no difference
in the rate of lymph node recurrence.
Survival rates
The survival rate for patients with gastric cancer was
compared with each level of depth of invasion (Figure 1).
Death from causes other than gastric cancer was considered
as censored data in the survival analysis. Post-operative
survival curve was poorer in proportion to the level of depth
of invasion (P<0.0001).
Discussion
The T factor of the TNM classification for gastric cancer was
determined by the UICC organisation, according to depth of
invasion into the gastric wall (Hermanek and Sobin, 1987).
The type of recurrence varied with the characteristics of
A
B
C
D
E
F
0 5
Time after operation (years)
10
Figure 1 Survival curve as related to each depth of invasion
following curative resection ofgastric cancer. The survival time of
patients with gastric cancer was shorter in proportion to the
degree of depth of invasion. A, mucosa; B, submucosa; C,
muscullaris propria; D, subserosa; E, serosa (exposed); F, serosa
(infiltrating adjacent tissue) and coexistence of exposed and
infiltrating serosa. (P<0.0001).
Table IV Sites of recurrence after resection of gastric cancer for each depth of invasion
Serosa (infiltrating),
Muscularis Serosa exposed and
Mucosa Submucosa propia Subserosa (exposed) infiltrating serosa
Site ofrecurrence (n = -l) (n =21) (n =35) (n=44) (n =200) (n=40)
Peritoneuma 2 (18.2) 4 (19.0) 7 (20.0) 6 (13.6) 72 (36.0) 13 (32.5)
Haematogenous 5 (45.5) 8 (38.1) 17 (48.6) 21 (47.7) 60 (30.0) 18 (45.0)
Liver 4 6 9 15 30 11
Lung 1 1 3 4 12 3
Bone 0 1 3 1 8 1
Brain 0 0 2 1 10 3
Local 2 (18.2) 2 (9.5) 5 (14.3) 5 (11.4) 31 (15.5) 6 (15.0)
Lymph node 0 0 1 (2.9) 0 10 (5.0) 3 (7.5)
Others, unknown 4 (36.4) 10 (47.6) 11 (31.4) 17 (38.6) 54 (27.0) 6 (15.0)
Percentages in brackets. ap =0.0251, rate ofperitoneal recurrence varied significantly among the six groups regarding depth ofinvasion.Characterisfics of gastric cancer
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gastnc cancer and the incidence was increased in proportion
to the depth of invasion. In the present work. age of the
patient. tumour advances. including the depth of invasion
and the grow-th potential of cancer cells and the extended
1Nmph node dissection were closely related to the recurrence
of the cancer and the prognosis (Maehara et al.. 1991a:
Adachi et al.. 1994). When we analysed recurrences with
regard to each depth of invasion. haematogenous recurrences.
in particular liver recurrence, were apparent. irrespective of
the depth of invasion. The rate of recurrences was lower in
cases of early depth of invasion in which the tumours invaded
mucosal and submucosal layers (Moreaux and Bougaran.
1993: Maehara et al., 1993). Therefore. the incidence of
haematogenous metastasis was relatively higher in cases of
early gastric cancer (Ichivoshi et al.. 1990: Orita et al.. 1992).
Haematogenous recurrence was thought to occur mainly
when cancer cells released from the primary site entered the
vessel system and were transported to the organ. where
attachment and proliferation occurred (Noguchi, 1990). The
main locus of vascular invasion was seen most frequently in
the submucosal layer (Noguchi. 1990)., thus liver metastasis
can occur even in the early stage of gastric cancer, in vascular
invasion-positive cases. We reported the possible role of
vascular and lyxmphatic spread of gastric cancer to distant
organs in advanced stages of the disease and that vascular
invasion and lymph node metastasis were independent risk
factors of synchronous and metachronous liver metastasis
(Maehara er al.. 1991b. 1995b: Moriguchi et al.. 1992a).
There are reports on the clinical significance of DNA
ploidy. oncogene. growth factor and tumour marker for
predicting the tumour progression and the survival of
patients (Korenaga et al.. 1988b: Maehara et al., 1990:
Joypaul et al.. 1994: Lee et al.. 1994: Hirono et al.. 1995). We
found that in proportion to the level of PCNA labelling of
gastric cancer tissues. the recurrence rate was increased and
the prognosis was poorer. PCNA is a highly conserved
36 kDa acidic protein and in conjunction with activator 1.
acts as a processivity factor for DNA polymerase a which is
directly involved in DNA synthesis. The level of PCNA
correlates with the proliferative state of cells determined by
the Ki-67 score. bromodeoxyuridine incorporation and flow
cytometrv (Waseem and Lane. 1990: Hall et al.. 1990). As
PCNA can be readily assayed using paraffin sections. the
prognostic significance of the proliferating activity of cancer
cells can be determined by the level of PCNA. The clinical
usefulness of the PCNA level for predicting prognosis of
patients with gastric cancer has been reported (Kakeji et al..
1991: Maeda et al.. 1994). When the PCNA level was
analysed by Cox regression analysis in these 155 cases. this
factor proved to be prognostically significant. The growth
potential of cancer cells is one approach to assess the
likelihood of death from a recurrence of the gastric cancer.
The undifferentiated tissue with infiltrative growth was
mainly noted in cases of an advanced level of invasion into
the serosal layer or adjacent organs (Moriguchi et al., 1992b).
Peritoneal recurrence is dominant for an advanced stage of
gastric cancer of the undifferentiated tissue type, serosal
invasion and lymph node metastasis. In these cases, the
tumour cells infiltrate the gastric wall and penetrate the
serosa. Undifferentiated cancer cells are thought to dissemi-
nate transserosally to the peritoneum. Moreover, in cases of
an advanced level of invasion. lymphatic and or vascular
routes account for spread of the cancer cells to the
peritoneum and distant organs (Maehara et al., 1991b.
1995b). With respect to lymph node dissection. extended
lymph node dissection was not significant in the univariate
analysis, however this factor was prognostically significant in
the multivariate analysis. as reported previously (Maehara et
al.. 1991a; Adachi et al.. 1994; Baba et al.. 1995). As a
number of factors showed a close relation, a multivariate
analysis is crucial for analysing the independent factors
involved in the clinical outcome.
Our analysis of all the data shows that serosal invasion.
growth potential and extended lymph node dissection are
important prognostic factors and the type of recurrence
varies at each level of invasion of the gastric tumour.
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